We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.47%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$15.3B
AUM Growth
+$2.76B
(+22%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
12.55%
Top 10 Holdings %
Top 10 Hldgs %
45.98%
Holding
1,005
New
144
Increased
321
Reduced
458
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$335M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$122M |
| 3 |
JPMorgan Chase
JPM
|
+$113M |
| 4 |
Cheniere Energy
CQP
|
+$111M |
| 5 |
ENBL
ENABLE MIDSTREAM PARTNERS, LP
ENBL
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DM
Dominion Energy Midstream Ptr LP
DM
|
+$55.1M |
| 2 |
Navient
NAVI
|
+$47.5M |
| 3 |
Macy's
M
|
+$17.7M |
| 4 |
Occidental Petroleum
OXY
|
+$17M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 54.25% |
| 2 | Financials | 6.56% |
| 3 | Healthcare | 3.56% |
| 4 | Consumer Discretionary | 2.58% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
926
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-125,655
| Closed | -$1.41M |
|
927
Albemarle
ALB
$13.5B
| – | – |
-4,200
| Closed | -$390K |
|
928
Aptiv
APTV
$12B
| – | – |
-10,832
| Closed | -$920K |
|
929
Arrowhead Research
ARWR
$12.1B
| – | – |
-116,402
| Closed | -$839K |
|
930
Brink's
BCO
$5.02B
| – | – |
-9,621
| Closed | -$686K |
|
931
BioCryst Pharmaceuticals
BCRX
$2.37B
| – | – |
-132,021
| Closed | -$630K |
|
932
Franklin Resources
BEN
$16.9B
| – | – |
-17,173
| Closed | -$596K |
|
|
BLUE
933
DELISTED
bluebird bio
BLUE
| – | – |
-122
| Closed | -$270K |
|
934
Citigroup
C
$222B
| – | – |
-19,196
| Closed | -$1.3M |
|
935
Chubb
CB
$140B
| – | – |
-2,122
| Closed | -$290K |
|
936
Crown Holdings
CCK
$12.8B
| – | – |
-9,950
| Closed | -$505K |
|
937
City Holding Co
CHCO
$1.97B
| – | – |
-5,799
| Closed | -$398K |
|
938
Centene
CNC
$31.3B
| – | – |
-10,572
| Closed | -$565K |
|
939
CNX Resources
CNX
$4.85B
| – | – |
-13,914
| Closed | -$215K |
|
940
Community Health Systems
CYH
$385M
| – | – |
-54,004
| Closed | -$214K |
|
|
DBVT
941
DBV Technologies
DBVT
$807M
| – | – |
-6,700
| Closed | -$1.55M |
|
942
EPAM Systems
EPAM
$4.69B
| – | – |
-1,811
| Closed | -$207K |
|
943
Freeport-McMoran
FCX
$90B
| – | – |
-11,747
| Closed | -$206K |
|
944
FTAI Aviation
FTAI
$22.2B
| – | – |
-181,622
| Closed | -$2.47M |
|
945
Huntington Ingalls Industries
HII
$11.3B
| – | – |
-2,709
| Closed | -$698K |
|
946
ImmunityBio
IBRX
$7.44B
| – | – |
-106,549
| Closed | -$414K |
|
947
Intel
INTC
$466B
| – | – |
-8,371
| Closed | -$436K |
|
948
Iron Mountain
IRM
$38.2B
| – | – |
-13,746
| Closed | -$452K |
|
949
ITT
ITT
$17.5B
| – | – |
-4,177
| Closed | -$205K |
|
950
Jack in the Box
JACK
$278M
| – | – |
-5,745
| Closed | -$490K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, ALPS Advisors held 1,005 positions worth $15.3B, up 22% from $12.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
ALPS Advisors deployed $1.92B of net new capital in Q2 2018, opening 144 new positions and adding to 321 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1,144 shares worth $323M.
By sector, the portfolio is most concentrated in Energy at 54% of assets, down from 56% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dominion Energy Midstream Ptr LP, an estimated $55.1M trimmed.
- ALPS Advisors's largest Q2 2018 buy was Berkshire Hathaway Class A: 1,144 shares worth $323M.
- ALPS Advisors added most to JPMorgan Chase in Q2 2018, an estimated $113M increase.
- ALPS Advisors's biggest Q2 2018 reduction was Dominion Energy Midstream Ptr LP, cutting an estimated $55.1M.
- ALPS Advisors fully exited BeOne Medicines Ltd in Q2 2018, selling an estimated $9.35M.
- ALPS Advisors's ten largest holdings make up 46% of its $15.3B portfolio in Q2 2018.
- ALPS Advisors opened 144 new positions and closed 80 in Q2 2018.
- ALPS Advisors's portfolio value rose 22% quarter-over-quarter to $15.3B.
Based on ALPS Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.